SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-008245
Filing Date
2023-05-17
Accepted
2023-05-17 21:08:54
Documents
1
Period of Report
2023-05-16

Document Format Files

Seq Description Document Type Size
1 form4-05182023_010546.html 4  
1 form4-05182023_010546.xml 4 4099
  Complete submission text file 0001415889-23-008245.txt   5588
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Menzel Garry E (Reporting) CIK: 0001556064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 23933545

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)